Cadmium (Cd)-based quantum dots (QDs), noted for their size-tunable optoelectronic properties and remarkable photoluminescence, have attracted considerable interest and found widespread commercial applications. Preparation methods for Cd-based QDs typically involve harsh, environmentally hazardous chemical and/or physical processes, whereas microbial biosynthesis offers a sustainable, green alternative. This review provides an overview of microbial production of Cd-based QDs (cadmium sulfide (CdS), cadmium selenide (CdSe), and cadmium telluride (CdTe)) using wild-type and genetically engineered bacteria, fungi, and viruses, with particular attention to the underlying biosynthesis mechanisms. Key proteins and peptides implicated in catalyzing or promoting QD biosynthesis include cystathionine γ-lyase, threonine dehydratase, sulfide-quinone reductase, phytochelatin (oligoglutathione peptides), and other metal-binding proteins such as metallothionein. The roles of capping agents (e.g., phosphates, L-cysteine, and glutathione), Cd (II) efflux genes, and extracellular polymeric substances are discussed. The application of this process in hazardous waste bioremediation, whereby Cd- or sulfur-containing waste is converted into valuable Cd-based QDs, is also addressed. Diverse applications are summarized, including QD-sensitized solar cells, fluorescent labeling, photocatalytic degradation of organic pollutants, and CdS-bacterial hybrid systems enabling photosynthetic production of organic compounds. This review contributes to a better understanding of Cd-based QD biosynthesis, although further efforts are needed to control synthesis and address biosafety concerns.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: